Remimazolam was associated with earlier extubation than midazolam in a retrospective surgical comparison.
What the supplied paper reports
The study reviewed 184 older patients undergoing laparoscopic cholecystectomy: 81 received remimazolam and 103 midazolam. Median extubation times were 33 and 42 minutes, respectively, and recovery-unit stays were also shorter with remimazolam. Recorded circulatory adverse events were comparable; neither group had documented respiratory depression.
What the findings cannot establish
The investigators did not use propensity matching or multivariable regression to control confounding rigorously. A single-center retrospective comparison can reflect differences in selection, practice and unmeasured risk. Zero observed respiratory events in this sample cannot establish absence of respiratory risk.
Implications for forensic review
For a delayed-emergence assessment, compare total anesthetic exposure, co-administered drugs, physiological status and the criteria used for extubation. A difference between group medians is not an expected recovery deadline for every patient. The source supports an association with recovery workflow while leaving a causal advantage and uncommon safety outcomes less certain.
Source and related reading
Source reviewed: Comparison of efficacy and safety of remimazolam and midazolam in elderly patients undergoing laparo (PMC13068910). The forensic applications above are interpretive analysis of the supplied paper.
Related reading: Midazolam Before Tonsil Surgery: Nonsignificant Recovery Differences Still Had Uncertainty.
Leave a Reply